What is the market doing?
What the tape says about UTHR
United Therapeutics Corporation is +73% over the past year while the S&P 500 is +23%: 50 points ahead of the market.
+73%
1-year return · S&P 500 +23%
- vs 200-day average
- +0.25%
vs 200-day average · close to trend
- RSI (14)
- 42
RSI (14) · neutral
- Below its 52-week high
- −13%
Below its 52-week high
Details›
- Last close2026-08-26
- $516.77
- 1 monthS&P 500 +3.7%
- −2.4%
- 1 yearS&P 500 +23%
- +73%
- 5 yearsS&P 500 +87%
- +187%
- vs 50-day average$532.19
- −2.9%
- 52-week high
- $596.76
- 52-week low
- $300.43
- Annualised volatility
- 41%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$4.6M
| Year | Return |
|---|---|
| 2026 (year to date) | +6.1% |
| 2025 | +38% |
| 2024 | +60% |
| 2023 | −21% |
| 2022 | +29% |
| 2021 | +42% |
| 2020 | +72% |
| 2019 | −19% |
| 2018 | −26% |
| 2017 | +3.2% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | +0.76% |
| Feb | 10 | 5 of 10 | −2.4% |
| Mar | 10 | 4 of 10 | −1.1% |
| Apr | 10 | 4 of 10 | +1.3% |
| May | 10 | 4 of 10 | +1.6% |
| Jun | 10 | 6 of 10 | +1.7% |
| Jul | 11 | 5 of 11 | +1.4% |
| Aug | 11 | 7 of 11 | +3.4% |
| Sep | 10 | 3 of 10 | −0.38% |
| Oct | 10 | 8 of 10 | +5.8% |
| Nov | 10 | 7 of 10 | +5.9% |
| Dec | 10 | 5 of 10 | +3.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
Ranks #6 of 28 by Smart Score